These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34181090)

  • 1. Polygenic Risk Scores to Identify CVD Risk and Tailor Therapy: Hope or Hype?
    German CA; Shapiro MD
    Curr Atheroscler Rep; 2021 Jun; 23(9):47. PubMed ID: 34181090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data.
    Agbaedeng TA; Noubiap JJ; Mofo Mato EP; Chew DP; Figtree GA; Said MA; van der Harst P
    Atherosclerosis; 2021 Sep; 333():48-55. PubMed ID: 34425527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease.
    Aragam KG; Dobbyn A; Judy R; Chaffin M; Chaudhary K; Hindy G; Cagan A; Finneran P; Weng LC; Loos RJF; Nadkarni G; Cho JH; Kember RL; Baras A; Reid J; Overton J; Philippakis A; Ellinor PT; Weiss ST; Rader DJ; Lubitz SA; Smoller JW; Karlson EW; Khera AV; Kathiresan S; Do R; Damrauer SM; Natarajan P
    J Am Coll Cardiol; 2020 Jun; 75(22):2769-2780. PubMed ID: 32498804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians.
    Wünnemann F; Sin Lo K; Langford-Avelar A; Busseuil D; Dubé MP; Tardif JC; Lettre G
    Circ Genom Precis Med; 2019 Jun; 12(6):e002481. PubMed ID: 31184202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease.
    Elliott J; Bodinier B; Bond TA; Chadeau-Hyam M; Evangelou E; Moons KGM; Dehghan A; Muller DC; Elliott P; Tzoulaki I
    JAMA; 2020 Feb; 323(7):636-645. PubMed ID: 32068818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
    Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C;
    Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.
    Lu X; Liu Z; Cui Q; Liu F; Li J; Niu X; Shen C; Hu D; Huang K; Chen J; Xing X; Zhao Y; Lu F; Liu X; Cao J; Chen S; Ma H; Yu L; Wu X; Wu X; Li Y; Zhang H; Mo X; Zhao L; Huang J; Wang L; Wen W; Shu XO; Takeuchi F; Koh WP; Tai ES; Cheng CY; Wong TY; Chang X; Chan MY; Gao W; Zheng H; Chen K; Chen J; He J; Tang CS; Lam KSL; Tse HF; Cheung CYY; Takahashi A; Kubo M; Kato N; Terao C; Kamatani Y; Sham PC; Heng CK; Hu Z; Chen YE; Wu T; Shen H; Willer CJ; Gu D
    Eur Heart J; 2022 May; 43(18):1702-1711. PubMed ID: 35195259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenic Risk Scores in Coronary Artery Disease and Atrial Fibrillation.
    Gladding PA; Legget M; Fatkin D; Larsen P; Doughty R
    Heart Lung Circ; 2020 Apr; 29(4):634-640. PubMed ID: 31974023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Risk of Coronary Artery Disease, Features of Atherosclerosis, and Coronary Plaque Burden.
    Christiansen MK; Nissen L; Winther S; Møller PL; Frost L; Johansen JK; Jensen HK; Guðbjartsson D; Holm H; Stefánsson K; Bøtker HE; Bøttcher M; Nyegaard M
    J Am Heart Assoc; 2020 Feb; 9(3):e014795. PubMed ID: 31983321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study.
    Schoepf IC; Thorball CW; Ledergerber B; Engel T; Raffenberg M; Kootstra NA; Reiss P; Hasse B; Marzolini C; Thurnheer C; Seneghini M; Bernasconi E; Cavassini M; Buvelot H; Kouyos R; Günthard HF; Fellay J; Tarr PE;
    Clin Infect Dis; 2021 Nov; 73(9):1597-1604. PubMed ID: 34091660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenic Risk Scores: The Next Step for Improved Risk Stratification in Coronary Artery Disease?
    Stein R; Ferrari F; García-Giustiniani D
    Arq Bras Cardiol; 2024 Sep; 121(9):e20240252. PubMed ID: 39352188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.
    Li L; Pang S; Starnecker F; Mueller-Myhsok B; Schunkert H
    Eur Heart J; 2024 May; 45(20):1843-1852. PubMed ID: 38551411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic risk scores in coronary artery disease.
    Rao AS; Knowles JW
    Curr Opin Cardiol; 2019 Jul; 34(4):435-440. PubMed ID: 30994529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygenic predisposition to breast cancer and the risk of coronary artery disease.
    D'Souza M; Schou M; Skals R; Weeke PE; Lee C; Smedegaard L; Madelaire C; Gerds TA; Poulsen HE; Hansen T; Grarup N; Pedersen O; Stender S; Engstrøm T; Fosbøl E; Nielsen D; Gislason G; Køber L; Torp-Pedersen C; Andersson C
    Int J Cardiol; 2019 Sep; 291():145-151. PubMed ID: 31155334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes.
    Lu T; Forgetta V; Yu OHY; Mokry L; Gregory M; Thanassoulis G; Greenwood CMT; Richards JB
    Cardiovasc Diabetol; 2020 Jan; 19(1):12. PubMed ID: 32000781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Bias in Polygenic Risk Prediction Models for Coronary Artery Disease.
    Gola D; Erdmann J; Läll K; Mägi R; Müller-Myhsok B; Schunkert H; König IR
    Circ Genom Precis Med; 2020 Dec; 13(6):e002932. PubMed ID: 33170024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics-based risk scores for prediction of premature coronary artery disease.
    Gupta R
    Indian Heart J; 2023; 75(5):327-334. PubMed ID: 37633460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of polygenic risk scores for coronary artery disease.
    Klarin D; Natarajan P
    Nat Rev Cardiol; 2022 May; 19(5):291-301. PubMed ID: 34811547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial and autophagy-lysosomal pathway polygenic risk scores predict Parkinson's disease.
    Dehestani M; Liu H; Sreelatha AAK; Schulte C; Bansal V; Gasser T
    Mol Cell Neurosci; 2022 Jul; 121():103751. PubMed ID: 35710056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic profiling using genome-wide significant coronary artery disease risk variants does not improve the prediction of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study and the Health 2000 Survey--a meta-analysis of three independent studies.
    Hernesniemi JA; Seppälä I; Lyytikäinen LP; Mononen N; Oksala N; Hutri-Kähönen N; Juonala M; Taittonen L; Smith EN; Schork NJ; Chen W; Srinivasan SR; Berenson GS; Murray SS; Laitinen T; Jula A; Kettunen J; Ripatti S; Laaksonen R; Viikari J; Kähönen M; Raitakari OT; Lehtimäki T
    PLoS One; 2012; 7(1):e28931. PubMed ID: 22295058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.